Warner Biddle and Christi Shaw, two prominent former executives at Gilead’s CAR-T division, will try to turn around an autoimmune cell therapy developer that’s lost most of its value since raising ...
Next-generation sequencing (NGS) is the future of GxP for biosafety and product characterization. This method of fast, sensitive, cost-efficient genetic sequencing can help evaluate viral content, ...